Cancer-associated fibroblasts: Mediators of head and neck tumor microenvironment remodeling

Biochim Biophys Acta Rev Cancer. 2023 Sep;1878(5):188940. doi: 10.1016/j.bbcan.2023.188940. Epub 2023 Jun 16.

Abstract

Cancer-associated fibroblasts (CAFs) are involved in critical aspects of head and neck squamous cell carcinoma (HNSCC) pathogenesis, such as the formation of a tumor-permissive extracellular matrix structure, angiogenesis, or immune and metabolic reprogramming of the tumor microenvironment (TME), with implications for metastasis and resistance to radiotherapy and chemotherapy. The pleiotropic effect of CAFs in TME is likely to reflect the heterogeneity and plasticity of their population, with context-dependent effects on carcinogenesis. The specific properties of CAFs provide many targetable molecules that could play an important role in the future therapy of HNSCC. In this review article, we will focus on the role of CAFs in the TME of HNSCC tumors. We will also discuss clinically relevant agents targeting CAFs, their signals, and signaling pathways, which are activated by CAFs in cancer cells, with the potential for repurposing for HNSCC therapy.

Keywords: Cancer therapy; Cancer-associated fibroblasts; Head and neck cancer; Resistance to therapy; Tumor microenvironment.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cancer-Associated Fibroblasts* / metabolism
  • Head and Neck Neoplasms* / metabolism
  • Humans
  • Signal Transduction
  • Squamous Cell Carcinoma of Head and Neck / metabolism
  • Tumor Microenvironment